Skip to main contentSkip to navigation
Sirius Investors

RBII Stock: Rising BioSciences, Inc. Stock Price, Analysis & Insights

Get live RBII stock price $0.00, comprehensive Rising BioSciences, Inc. stock analysis, charts, news, and expert forecast. Real-time RBII stock data and investment insights.

0.00
0.00%Today
RBIIRising BioSciences, Inc. • Other OTC • Healthcare
Market Cap
4.99K
Volume
282.90K
52W High
0.00
52W Low
0.00

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Rising BioSciences, Inc., situated in Sheridan, Wyoming, focuses on the creation and production of both topical and oral pharmaceutical goods, which notably feature medical marijuana products.

Company Information

CEO
Arthur Hall
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
N/A

Contact Information

Address
30 North Gould Street
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Pharmaceuticals

Investment Highlights

Strong presence in the Healthcare sector with established market position

Higher growth potential with elevated volatility (Beta: 4.96)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Rising BioSciences, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Rising BioSciences, Inc.
  • Investors should consider how Rising BioSciences, Inc. fits within their overall portfolio allocation

Market Cap

4.99K

Beta

4.96

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.